Live Breaking News & Updates on Pharmaceuticals

Stay updated with breaking news from Pharmaceuticals . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AstraZeneca Plc Digital Transformation Strateg Report 2023: Technology Focus, Initiatives, Acquisitions, Partnership and Acquisition Network Map, ICT Budget, and Contracts

/PRNewswire/ The "AstraZeneca Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. This report. ....

India , Qure , Xizang , China , Dublin , Ireland , Laura-wood , Healthcare-iot-innovation-center , Acquisition-network , E-st-office-hours-call , Astrazeneca-plc , Nvidia

CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference

/PRNewswire/ The 42nd J.P. Morgan Annual Healthcare Conference（"JPMHC"）2024 is taking place on January 8-11 at San Fracisco, USA, members of Sichuan. ....

United-states , China , Sichuan-kelun , Biotech-biopharmaceutical-co-ltd , Kelun-group , Annual-healthcare-conference , San-fracisco , Pacific-standard-time , Kelun-biotech , Health-care-amp-hospitals , Medical-pharmaceuticals-

WBA (Walgreens Boots Alliance) Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, Partnership, Investment & Acquisition Network Map, and Other Innovation Programs

/PRNewswire/ The "WBA - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. Walgreens Boots Alliance Inc. ....

Dublin , Ireland , Laura-wood , Liz-earle , Walgreens , Microsoft , E-st-office-hours-call , Verizon , Walgreens-boots-alliance-inc , Alliance-healthcare , Philips , Investment-acquisition-network

Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference

/PRNewswire/ Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business. ....

South-korea , San-francisco , California , United-states , New-jersey , Incheon , Inch-on-gwangyoksi , Boston , Massachusetts , Prnewswire-samsung-biologics , Samsung-biologics , Samsung-biologics-america

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）

/PRNewswire/ On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor. ....

Canada , Taiwan , Shanghai , China , Hong-kong , Beijing , Macau , Chinese , European-union , Abbisko-therapeutics-co-ltd , European-medicines-agency